BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 3891306)

  • 1. Acebutolol. A review of its pharmacological properties and therapeutic efficacy in hypertension, angina pectoris and arrhythmia.
    Singh BN; Thoden WR; Ward A
    Drugs; 1985 Jun; 29(6):531-69. PubMed ID: 3891306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acebutolol: a review of its pharmacology, pharmacokinetics, clinical uses, and adverse effects.
    Singh BN; Thoden WR; Wahl J
    Pharmacotherapy; 1986; 6(2):45-63. PubMed ID: 3012486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nadolol: a review of its pharmacological properties and therapeutic efficacy in hypertension and angina pectoris.
    Heel RC; Brogden RN; Pakes GE; Speight TM; Avery GS
    Drugs; 1980 Jul; 20(1):1-23. PubMed ID: 6105067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atenolol: a review of its pharmacological properties and therapeutic efficacy in angina pectoris and hypertension.
    Heel RC; Brogden RN; Speight TM; Avery GS
    Drugs; 1979 Jun; 17(6):425-60. PubMed ID: 38096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacologic properties of acebutolol: relationship of hydrophilicity to central nervous system penetration.
    Abernethy DR; Arendt RM; Greenblatt DJ
    Am Heart J; 1985 May; 109(5 Pt 2):1120-5. PubMed ID: 2859774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acebutolol: ten years of experience.
    De Bono G; Kaye CM; Roland E; Summers AJ
    Am Heart J; 1985 May; 109(5 Pt 2):1211-3. PubMed ID: 2859785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacology of acebutolol in animals].
    Basil B
    Nouv Presse Med; 1975 Dec; 4(46 Suppl):3217-21. PubMed ID: 1219628
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacological basis for the therapy of cardiovascular disease with beta-adrenoceptor blocking drugs (author's transl)].
    Lemmer B
    Herz; 1982 Jun; 7(3):168-78. PubMed ID: 6124492
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ancillary pharmacologic properties of acebutolol: cardioselectivity, partial agonist activity, and membrane-stabilizing activity.
    Giacomini JC; Thoden WR
    Am Heart J; 1985 May; 109(5 Pt 2):1137-44. PubMed ID: 2859777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antihypertensive effects of 12 beta adrenoceptor antagonists in conscious spontaneously hypertensive rats: relationship to changes in plasma renin activity, heart rate and sympathetic nerve function.
    Antonaccio MJ; High J; DeForrest JM; Sybertz E
    J Pharmacol Exp Ther; 1986 Jul; 238(1):378-87. PubMed ID: 2873238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bisoprolol. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in hypertension and angina pectoris.
    Lancaster SG; Sorkin EM
    Drugs; 1988 Sep; 36(3):256-85. PubMed ID: 2903820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Betaxolol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in hypertension.
    Beresford R; Heel RC
    Drugs; 1986 Jan; 31(1):6-28. PubMed ID: 2866947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Anti-arrhythmic and anti-anginal properties of acebutolol].
    Biron P; Tremblay G; Nadeau R; Proulx A
    Union Med Can; 1974 Nov; 103(11):1974-6. PubMed ID: 4156439
    [No Abstract]   [Full Text] [Related]  

  • 14. Pharmacological properties of diacetolol (M & B 16,942), a major metabolite of acebutolol.
    Basil B; Jordan R
    Eur J Pharmacol; 1982 May; 80(1):47-56. PubMed ID: 6124437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pulmonary effects of acebutolol, a "cardioselective" beta adrenergic blocking agent.
    DiBianco R; Dickie KJ; Singh S; Katz RJ; Costello RB; Gottdiene JS; Laddu AR; Fletcher RD
    Int J Clin Pharmacol Ther Toxicol; 1982 Jan; 20(1):1-7. PubMed ID: 6120142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metoprolol: a review of its pharmacological properties and therapeutic efficacy in hypertension and angina pectoris.
    Brogden RN; Heel RC; Speight TM; Avery GS
    Drugs; 1977 Nov; 14(5):321-48. PubMed ID: 201441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low-dose acebutolol given once daily in the treatment of chronic angina pectoris.
    PiƱa IL; Smith EV; Weidler DJ
    J Clin Pharmacol; 1988 May; 28(5):427-30. PubMed ID: 3392240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Celiprolol. A preliminary review of its pharmacodynamic and pharmacokinetic properties and its therapeutic use in hypertension and angina pectoris.
    Riddell JG; Shanks RG; Brogden RN
    Drugs; 1987 Oct; 34(4):438-58. PubMed ID: 2890513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bevantolol. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in hypertension and angina pectoris.
    Frishman WH; Goldberg RJ; Benfield P
    Drugs; 1988 Jan; 35(1):1-21. PubMed ID: 2894292
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative haemodynamic dose-response effects of intravenous propranolol, acebutolol and penbutolol in angina pectoris.
    Silke B; Nelson GI; Verma SP; Ahuja RC; Okoli RC; Hussain M; Taylor SH
    Herz; 1984 Feb; 9(1):57-64. PubMed ID: 6368345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.